$2.46T
Total marketcap
$74.67B
Total volume
BTC 50.68%     ETH 14.81%
Dominance

Miravant Medical MRVT Stock

0 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
9.46K USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
100 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Miravant Medical Price Chart

Miravant Medical MRVT Financial and Trading Overview

Miravant Medical stock price 0.0000 USD
Previous Close 1.0E-6 USD
Open 1.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 1.0E-6 - 1.0E-6 USD
52 Week Range 1.0E-6 - 0.003 USD
Volume 90 USD
Avg. Volume 0 USD
Market Cap 9.46K USD
Beta (5Y Monthly) 12.083098
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (6.57%)
Ex-Dividend Date N/A
1y Target Est N/A

MRVT Valuation Measures

Enterprise Value 15.56M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.167

Trading Information

Miravant Medical Stock Price History

Beta (5Y Monthly) 12.083098
52-Week Change -99.66%
S&P500 52-Week Change 20.43%
52 Week High 0.003 USD
52 Week Low 1.0E-6 USD
50-Day Moving Average 1.0E-5 USD
200-Day Moving Average 0.00140035 USD

MRVT Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 0
Float N/A
Short Ratio 0
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short 0
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 3:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2004
Most Recent Quarter (mrq) September 30, 2005
Next Fiscal Year End December 31, 2005

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -109.58%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -13334000 USD
Net Income Avi to Common (ttm) -15336000 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.86M USD
Total Cash Per Share (mrq) 0.1 USD
Total Debt (mrq) 10.43M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.723
Book Value Per Share (mrq) -0.368

Cash Flow Statement

Operating Cash Flow (ttm) -11206000 USD
Levered Free Cash Flow (ttm) -6919375 USD

Profile of Miravant Medical

Country United States
State CA
City Santa Barbara
Address 336 Bollay Drive
ZIP 93117
Phone 805-685-9880
Website N/A
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 47

Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for the treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.

Q&A For Miravant Medical Stock

What is a current MRVT stock price?

Miravant Medical MRVT stock price today per share is 0.0000 USD.

How to purchase Miravant Medical stock?

You can buy MRVT shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Miravant Medical?

The stock symbol or ticker of Miravant Medical is MRVT.

Which industry does the Miravant Medical company belong to?

The Miravant Medical industry is Drug Manufacturers-Specialty & Generic.

How many shares does Miravant Medical have in circulation?

The max supply of Miravant Medical shares is 0.

What is Miravant Medical Price to Earnings Ratio (PE Ratio)?

Miravant Medical PE Ratio is now.

What was Miravant Medical earnings per share over the trailing 12 months (TTM)?

Miravant Medical EPS is 0 USD over the trailing 12 months.

Which sector does the Miravant Medical company belong to?

The Miravant Medical sector is Healthcare.